Molecular Pharmaceutics is a peer-reviewed scientific journal, published since 2004 by the American Chemical Society. MP is currently indexed in: Chemical Abstracts Service (CAS), SCOPUS, EBSCOhost, British Library, PubMed, CABI, Web of Science, Proquest and SwetsWise. The current Editor is Gordon L. Amidon. Molecular Pharmaceutics publishes the results of original research that contributes significantly to the molecular mechanistic understanding of drug delivery and drug delivery systems. The journal encourages contributions describing research at the interface of drug discovery and drug development. Scientific areas within the scope of the journal include physical and pharmaceutical chemistry, biochemistry and biophysics, molecular and cellular biology, and polymer and materials science as they relate to drug and drug delivery system efficacy. Theoretical and experimental peer-reviewed communications, full-length research papers, brief articles, and critical reviews are welcomed. Molecular Pharmaceutics publishes Reviews, Articles, Brief Articles and Communications. MP has an Impact Factor of 5.400 as reported by the 2010 Journal Citation Reports by Thomson Reuters. The proper
Chocolate-flavored pills for children who hate taking medicine. Several drugs combined into one daily pill for seniors who have trouble remembering to take their medications. Drugs printed at your local pharmacy at personalized ...
Jun 24, 2024
0
31
Antibody treatments exist for many diseases, but require injections or IV infusions, which are painful, inconvenient and carry risks. Now, a team of researchers at the University of Connecticut has created a way to deliver ...
Apr 13, 2023
0
32
A research group at Uppsala University has developed a simple and effective artificial blood-brain barrier model that can be used to determine how well antibody-based therapies can enter the brain. Today animal experimentation ...
Feb 24, 2023
0
50
A plant virus that infects legumes, called cowpea mosaic virus, has a special power that you may not have known about: when injected into a tumor, it triggers the immune system to treat the cancer—even metastatic cancer—and ...
Apr 28, 2022
0
1054
Scientists at Oregon State University have made a key advance against dangerous and costly surgical site infections, the type of infection most commonly associated with health care procedures.
Feb 25, 2022
0
30
Tens of millions of patients around the world suffer from persistent and potentially life-threatening wounds. For these chronic wounds, which are also a leading cause of amputation, there are treatments, but the cost of existing ...
Jul 19, 2021
0
13
As many as one in three women treated for breast cancer undergo unnecessary procedures, but a new method for diagnosing it could do a better job distinguishing between benign and aggressive tumors.
Apr 30, 2018
0
768
A team led by Fengzhi Li, PhD, of Roswell Park Cancer Institute has reported significant new findings regarding the chemical structure of the novel anticancer agent FL118. The research, which included comparative analysis ...
Jan 2, 2014
0
0
An approach called radiotheranostics involves a combination of a different kind for the treatment of cancer—namely, the combination of therapeutic and diagnostic techniques using radionuclides, chemical elements with unstable ...
Nov 29, 2021
0
1
If there's one take-home message for the general public about the coronavirus vaccines approved in the U.S., it's that they are remarkably effective.
May 20, 2021
0
6
